4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0000950170-24-024298
SVP, Head of Finance & Admin. sold 12,740 shares at an average $28.05 ($357,296)
- SVP, Head of Finance & Admin. acquired 12,740 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-02-29 | Option exercise 10b5-1 | +3,429 | $1.03 | $3,532 | 127,657 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-02-29 | Sale 10b5-1 | −3,429 | $27.50 | $94,298 | 124,228 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-01 | Option exercise 10b5-1 | +9,311 | $1.03 | $9,590 | 133,539 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-01 | Sale 10b5-1 | −8,747 | $28.22 | $246,840 | 124,792 | D |
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-01 | Sale 10b5-1 | −564 | $28.65 | $16,159 | 124,228 | D |
| Derivatives | |||||||
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-02-29 | Option exercise · Stock option (right to buy) 10b5-1 | −3,429 | 9,311 | D | ||
| Scalzo Richard William SVP, Head of Finance & Admin. | 2024-03-01 | Option exercise · Stock option (right to buy) 10b5-1 | −9,311 | 0 | D | ||
| Open-market sales · 12,740 sh · avg $28.05 · $357,296 | |||||||
Loading xslF345X05/ownership.xml…